{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:28:14Z","timestamp":1761060494117},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1992,1,1]],"date-time":"1992-01-01T00:00:00Z","timestamp":694224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1992,1,1]],"date-time":"1992-01-01T00:00:00Z","timestamp":694224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Clinical Nutrition"],"published-print":{"date-parts":[[1992,1]]},"DOI":"10.1093\/ajcn\/55.1.206s","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T20:32:09Z","timestamp":1515184329000},"page":"206S-210S","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Phenylpropanolamine and blood pressure: a review of prospective studies"],"prefix":"10.1016","volume":"55","author":[{"given":"JP","family":"Morgan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FR","family":"Funderburk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/ajcn\/55.1.206s_bib1","series-title":"Phenylpropanolamine: risks, benefits and controversies","first-page":"11","article-title":"A history of therapeutic uses of phenylpropanolamine in North America","author":"Silverman","year":"1985"},{"key":"10.1093\/ajcn\/55.1.206s_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0002-9343(90)90299-S","article-title":"Adverse drug effects attributed to phenylpropanolamine: a review of 142 case reports","volume":"89","author":"Lake","year":"1989","journal-title":"Am J Med"},{"key":"10.1093\/ajcn\/55.1.206s_bib3","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1001\/jama.1984.03350140044023","article-title":"Toxicity of over-the-counter stimulants","volume":"252","author":"Pentel","year":"1984","journal-title":"JAMA"},{"key":"10.1093\/ajcn\/55.1.206s_bib4","first-page":"569","article-title":"Invited commentary: phenylpropanolamine and the medical literature: a thorough reading is required.","volume":"14","author":"Morgan","year":"1990","journal-title":"Int J Obes"},{"key":"10.1093\/ajcn\/55.1.206s_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/clpt.1987.100","article-title":"Persuading by citation: an analysis of the references of fifty three published reports of phenylpropanolamine\u2019s clinical toxicity","volume":"42","author":"Puder","year":"1987","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/ajcn\/55.1.206s_bib6","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1001\/jama.1989.03420220081031","article-title":"Determinants of the pressor effect of phenylpropanolamine in healthy subjects","volume":"261","author":"Blackbum","year":"1989","journal-title":"JAMA"},{"key":"10.1093\/ajcn\/55.1.206s_bib7","first-page":"31","article-title":"The congressional hearings\u2014who\u2019s saying what.","author":"Baum","year":"1990","journal-title":"The Bariatrician Summer"},{"key":"10.1093\/ajcn\/55.1.206s_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5694\/j.1326-5377.1979.tb128964.x","article-title":"Hypertension and postural hypotension induced by phenylpropanolamine (Trimolets)","volume":"1","author":"Horowitz","year":"1979","journal-title":"Med J Aust"},{"key":"10.1093\/ajcn\/55.1.206s_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(80)90490-0","article-title":"Hypertensive responses induced by phenylpropanolamine in anorectic and decongestant preparations","author":"Horowitz","year":"1980","journal-title":"Lancet"},{"key":"10.1093\/ajcn\/55.1.206s_bib10","series-title":"Phenylpropanolamine: risks, benefits and controversies","first-page":"180","article-title":"Norephedrine and norpseudoephedrine: pharmacologically and clinically distinct isomers of phenylpropanolamine","author":"Morgan","year":"1985"},{"key":"10.1093\/ajcn\/55.1.206s_bib11","first-page":"115","article-title":"Therapeutic doses of phenylpropanolamine increase systolic blood pressure","volume":"9","author":"Pentel","year":"1985","journal-title":"Int J Obes"},{"key":"10.1093\/ajcn\/55.1.206s_bib12","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.1985.03350410037007","article-title":"Phenylpropanolamine and blood pressure\u2014in reply","volume":"253","author":"Pentel","year":"1985","journal-title":"JAMA"},{"key":"10.1093\/ajcn\/55.1.206s_bib13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/clpt.1985.77","article-title":"Propranolol antagonism of phenylpropanolamine-induced hypertension","volume":"37","author":"Pentel","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/ajcn\/55.1.206s_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.2042-7158.1987.tb06954.x","article-title":"Adrenergic receptor subtype activation by (+)-, (-)- and (\u00b1)-norephedrine in the pithed rat","volume":"39","author":"Moya-Huff","year":"1987","journal-title":"J Pharm Pharmacol"},{"key":"10.1093\/ajcn\/55.1.206s_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00004714-198304000-00007","article-title":"Psychomotor stimulant-induced mania in a genetically predisposed patient: a review of the literature and report of a case","volume":"3","author":"Lake","year":"1983","journal-title":"J Clin Psychopharmacol"},{"key":"10.1093\/ajcn\/55.1.206s_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9343(88)90583-9","article-title":"A double dose of phenylpropanolamine causes transient hypertension","volume":"85","author":"Lake","year":"1988","journal-title":"Am J Med"},{"key":"10.1093\/ajcn\/55.1.206s_bib17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0002-9343(89)90341-0","article-title":"Transient hypertension after two phenylpropanolamine diet aids and the effects of caffeine: a placebo controlled follow-up study","volume":"86","author":"Lake","year":"1989","journal-title":"Am J Med"},{"key":"10.1093\/ajcn\/55.1.206s_bib18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/j.1552-4604.1987.tb03089.x","article-title":"Phenylpropanolamine: effects of subjective and cardiovascular variables at recommended over-the-counter dose levels","volume":"27","author":"Liebson","year":"1987","journal-title":"J Clin Pharmacol"},{"key":"10.1093\/ajcn\/55.1.206s_bib19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/clpt.1986.153","article-title":"The effect of phenylpropanolamine on ambulatory blood pressure","volume":"40","author":"Goodman","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"10.1093\/ajcn\/55.1.206s_bib20","first-page":"74","article-title":"The effects of phenylpropanolamine hydrochloride in overweight patients with controlled stable hypertension","volume":"46","author":"Bradley","year":"1989","journal-title":"Curr Ther Res"},{"key":"10.1093\/ajcn\/55.1.206s_bib21","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.7326\/0003-4819-111-12-1043","article-title":"The safety of phenylpropanolamine in patients with stable hypertension","volume":"111","author":"Kroenke","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1093\/ajcn\/55.1.206s_bib22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.1987.03400020078035","article-title":"The potent pressor effect of phenylpropanolamine in patients with autonomic impairment","volume":"258","author":"Biaggoni","year":"1987","journal-title":"JAMA"},{"key":"10.1093\/ajcn\/55.1.206s_bib23","first-page":"575","article-title":"Phenylpropanolamine and caffeine use among diet center clients","volume":"14","author":"Lake","year":"1990","journal-title":"Int J Obes"},{"year":"1975","series-title":"Applied multiple regression\/correlation analysis in the behavioral sciences","author":"Cohen","key":"10.1093\/ajcn\/55.1.206s_bib24"}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523315326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523315326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ajcn\/article-pdf\/55\/1\/206S\/24066063\/206s.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T17:28:15Z","timestamp":1727458095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002916523315326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1992,1]]}},"alternative-id":["S0002916523315326"],"URL":"https:\/\/doi.org\/10.1093\/ajcn\/55.1.206s","relation":{},"ISSN":["0002-9165"],"issn-type":[{"type":"print","value":"0002-9165"}],"subject":[],"published":{"date-parts":[[1992,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenylpropanolamine and blood pressure: a review of prospective studies","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/ajcn\/55.1.206s","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1992 American Society for Nutrition. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}